Test Serum Clinical Study

NCT ID: NCT07200635

Last Updated: 2025-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-23

Study Completion Date

2025-09-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This 4-week, mono-centric clinical study employed a randomized three-arm design to evaluate the efficacy of a test serum. The study compared three interventions: the test serum used alone, the test serum used in combination with hyaluronic acid (HA) injection, and HA injection alone. It aimed to assess their effects on skin quality and wrinkles in 90 healthy Chinese female subjects aged 25-40. Evaluations were conducted at multiple timepoints through clinical assessments, instrumental measurements, and image analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Redness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Serum Application Regimen

Group Type OTHER

Facial serum application

Intervention Type OTHER

Dosage on face: About 0.5g/face for serum.

Combination Regimen

Group Type OTHER

HA injection

Intervention Type OTHER

Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.

Facial serum application

Intervention Type OTHER

Dosage on face: About 0.5g/face for serum.

Injection-Exclusive Regimen

Group Type OTHER

HA injection

Intervention Type OTHER

Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HA injection

Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.

Intervention Type OTHER

Facial serum application

Dosage on face: About 0.5g/face for serum.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Chinese female with 25-40 years old.
2. All skin types by subjects' self-perceived.
3. Willing to perform HA injection.
4. Did not perform any of the beauty procedure projects in the past 6 months.
5. Lack of hydration, radiance, brightness, smoothness, firmness and elasticity by self-claimed.
6. Presenting with corresponding severity for the attribute evaluated by Dermatologist included:

* Radiance, smoothness, elasticity, cheek plumpness and firmness: 3≤grade≤6.
* Global fine lines: 3≤grade.
* Underneath eye wrinkles: 2≤grade≤5.
* Forehead wrinkles: 1\<grade≤4.
* Glabella wrinkles: 1\<grade.
7. All accept not to use any cosmetics, skincare products, beauty equipment, all topical medications and cleansing products on face at visit days.
8. Did not participate any clinical test or cosmetic product test on skin within 1 months.
9. No disagreement of dermatologist because of other reasons that exclude the participation of the volunteer.
10. In general, good health at the time of the study.
11. Willing and able to participate as evidenced by signing of informed consent \& photo release form.
12. Must be willing to comply with all study protocol requirements.

Exclusion Criteria

1. Pregnant or breast-feeding woman or woman planning pregnancy during the study.
2. Subject deprived of rights by a court or administrative order.
3. Major subject to a guardianship order.
4. Subject residing in a health or social care establishment.
5. Patient in an emergency setting.
6. Subject with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema).
7. Subject presenting a stable or progressive serious disease (per investigator's assessment).
8. Immuno-compromised subject.
9. Subject with history of allergy to cosmetic or personal care products or ingredients.
10. Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
11. Subject with history of sunlight sensitivity or allergies.
12. Subject regularly practicing aquatic or nautical sports.
13. Subject regularly attending a sauna.
14. Subject with physical highly sensitive constitution.
15. Subject with cardiovascular or circulatory history.
16. Subject with a history of skin cancer or malignant melanoma.
17. Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study.
Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ChinaNorm

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai China-norm Quality Technical Service Co., Ltd.

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C25005046

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effects of Cosmetic Acupuncture
NCT06952959 RECRUITING NA